151 related articles for article (PubMed ID: 29599698)
21. Impact of systemic alitretinoin treatment on skin barrier gene and protein expression in patients with chronic hand eczema.
Kumari V; Timm K; Kühl AA; Heine G; Worm M
Br J Dermatol; 2016 Dec; 175(6):1243-1250. PubMed ID: 27480504
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics, efficacy and safety of alitretinoin in moderate or severe chronic hand eczema.
Schmitt-Hoffmann AH; Roos B; Sauer J; Spickermann J; Stoeckel K; Edwards D; van de Wetering J; Coenraads PJ; Maares J
Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():29-34. PubMed ID: 21443602
[TBL] [Abstract][Full Text] [Related]
23. Alitretinoin for the treatment of severe chronic eczema of the hands.
Napolitano M; Potestio L; De Lucia M; Nocerino M; Fabbrocini G; Patruno C
Expert Opin Pharmacother; 2022 Feb; 23(2):159-167. PubMed ID: 34789049
[TBL] [Abstract][Full Text] [Related]
24. Alitretinoin Compliance in Patients with Chronic Hand Eczema.
Seol JE; Kim JU; Hong SM; Cho GJ; Jin WJ; Park SH; Park IH; Jung SY; Kim H
Ann Dermatol; 2021 Feb; 33(1):46-51. PubMed ID: 33911811
[TBL] [Abstract][Full Text] [Related]
25. Alitretinoin: A Review in Severe Chronic Hand Eczema.
Blair HA; Scott LJ
Drugs; 2016 Sep; 76(13):1271-1279. PubMed ID: 27438290
[TBL] [Abstract][Full Text] [Related]
26. Alitretinoin and acitretin in severe chronic hand eczema; results from a retrospective daily practice study.
Politiek K; Christoffers WA; Coenraads PJ; Schuttelaar MA
Dermatol Ther; 2016 Sep; 29(5):364-371. PubMed ID: 27146260
[TBL] [Abstract][Full Text] [Related]
27. Safety of alitretinoin for severe refractory chronic hand eczema: Clinical studies and postmarketing surveillance.
Morris M; Schifano L; Fong R; Graff O
J Dermatolog Treat; 2016; 27(1):54-8. PubMed ID: 25886084
[TBL] [Abstract][Full Text] [Related]
28. Alitretinoin: An Update of Real-World Evidence in The Management of Chronic Hand Dermatitis.
Gooderham MJ
Skin Therapy Lett; 2018 Jul; 23(4):1-4. PubMed ID: 30086182
[TBL] [Abstract][Full Text] [Related]
29. Everyday clinical experience of alitretinoin in the treatment of severe chronic hand eczema: seven case studies.
English J; Graham-Brown R; de Sica Chapman A; Alexandroff AB
Clin Exp Dermatol; 2011 Mar; 36 Suppl():1-2. PubMed ID: 21309810
[TBL] [Abstract][Full Text] [Related]
30. Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial.
Smith IL; Gilberts R; Brown S; Fernandez C; Nixon J; Reynolds C; Smith C; Lear JT; Sunderland L; Green C; Goodfield M; Cowdell F; Hampton P; Barker A; Vargas-Palacios A; Tubeuf S; Wittmann M
BMJ Open; 2022 Feb; 12(2):e060029. PubMed ID: 35197358
[TBL] [Abstract][Full Text] [Related]
31. Clinical evaluation and assessment of the therapeutic efficacy of alitretinoin in a group of patients with chronic hand eczema refractory to topical steroid therapy.
Gola M; Milanesi N; D'Erme AM
G Ital Dermatol Venereol; 2014 Aug; 149(4):435-9. PubMed ID: 25068232
[TBL] [Abstract][Full Text] [Related]
32. Use of Longitudinal Dose-Response Modeling to Support the Efficacy and Tolerability of Alitretinoin in Severe Refractory Chronic Hand Eczema (CHE).
Schmith GD; Singh R; Gomeni R; Graff O; Hamedani AG; Troughton JS; Learned SM
CPT Pharmacometrics Syst Pharmacol; 2015 Apr; 4(4):255-62. PubMed ID: 26225249
[TBL] [Abstract][Full Text] [Related]
33. Effective treatment of chronic hand dermatitis with 36 continuous months of alitretinoin administration: report of three cases.
Gulliver WP; Baker KA
J Cutan Med Surg; 2012; 16(4):267-71. PubMed ID: 22784520
[TBL] [Abstract][Full Text] [Related]
34. Oral Alitretinoin in the Treatment of Severe Refractory Chronic Hand Eczema in the Spanish National Health System: Description and Analysis of Current Clinical Practice.
Urrutia S; Roustan G; Plazas MJ; Armengol S; Paz S; Lizan L
Actas Dermosifiliogr; 2016 Mar; 107(2):142-8. PubMed ID: 26363930
[TBL] [Abstract][Full Text] [Related]
35. Open-label exploratory study of acitretin for the treatment of severe chronic hand dermatitis.
Tan J; Maari C; Nigen S; Bolduc C; Bissonnette R
J Dermatolog Treat; 2015; 26(4):373-5. PubMed ID: 25102893
[TBL] [Abstract][Full Text] [Related]
36. Effects of alitretinoin on quality of life of patients having chronic hand eczema: an observational study.
Gola M; D'Erme AM; Milanesi N; Marmugi L
Dermatitis; 2013; 24(4):166-9. PubMed ID: 23857016
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of alitretinoin for chronic hand eczema under daily practice conditions: results of the TOCCATA open study comprising 680 patients.
Diepgen TL; Pfarr E; Zimmermann T
Acta Derm Venereol; 2012 May; 92(3):251-5. PubMed ID: 22281779
[TBL] [Abstract][Full Text] [Related]
38. Alitretinoin--its use in intractable hand eczema and other potential indications.
Petersen B; Jemec GB
Drug Des Devel Ther; 2009 Sep; 3():51-7. PubMed ID: 19920921
[TBL] [Abstract][Full Text] [Related]
39. [Response to treatment with oral alitretinoin in patients with chronic hand eczema that is refractory to treatment with potent topical corticosteroids: experience in 15 patients].
Aguayo-Leiva IR; Urrutia S; Jaén-Olasolo P
Actas Dermosifiliogr; 2011 Oct; 102(8):616-22. PubMed ID: 21354545
[TBL] [Abstract][Full Text] [Related]
40. Oral alitretinoin: a review of the clinical pharmacokinetics and pharmacodynamics.
Schmitt-Hoffmann AH; Roos B; Schoetzau A; Leese PT; Meyer I; van de Wetering J; Kovacs P
Expert Rev Clin Pharmacol; 2012 Jul; 5(4):373-88. PubMed ID: 22943117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
